Colonic Perforation After Treatment With Nivolumab in Esophageal Cancer: A Case Report

Clicks: 177
ID: 272965
2021
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
With the advent of checkpoint inhibitors, it has opened up opportunities for numerous cancer patients. However, as is the case with every treatment, complications need to be weighed. Gastrointestinal adverse effects, such as diarrhea and colitis are well-known complications for checkpoint inhibitors …
Reference Key
hj2021annalscolonic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Cho HJ;Kim WR;Kim JH;Kim DH;Kim DJ;Kang H;;
Journal Annals of coloproctology
Year 2021
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/34167190
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine case reports pmid:34167190 pmc8359691 doi:10.3393/ac.2020.00213.0030 hye jung cho woo ram kim haeyoun kang

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.